Tata Digital infuses Rs 100 cr debt in online medicine startup 1mg: Report

The move ahead of the Gurugram-based firm's acquisition by the Tata Sons arm

online pharmacy, epharmancy
The acquisition is expected to help Tata strengthen its e-commerce initiatives
BS Reporter Bengaluru
2 min read Last Updated : Apr 19 2021 | 9:00 PM IST
Tata Sons’ digital services subsidiary Tata Digital has infused debt money in online medicine startup 1mg. Tata Digital is in the final stages to acquire a controlling stake in the Gurugram-based company. As per regulatory filings, Tata Digital is picking up Rs 100 crore worth compulsorily convertible debentures or CCDs in 1mg, according to Entrackr, a platform that tracks tech companies.

1mg has allotted 29,054 CCDs at a price of Rs 34,417.87 per debenture to raise the sum. The firm has already received Rs 25 crore while the remaining Rs 75 crore will be infused at a later stage. The Entrackr report said Tata Digital’s investment has valued the eight-year-old firm at $240 million.

Tata Digital is reportedly expected to acquire over 50 per cent stake in 1mg and the companies have been in talks since last November. The acquisition is expected to help Tata strengthen its e-commerce initiatives. The deal comes at a time when e-commerce sales, especially of food, groceries and healthcare products, have soared in India as the Covid-19 pandemic has spurred a shift to online shopping.

Last month, it was reported that Tata Sons Pvt Ltd has agreed to acquire control of India’s largest online grocer BigBasket, according to a filing with the Competition Commission of India (CCI). The deal was valued at more than $1 billion.

Tata Digital has proposed to buy 64.3 per cent of an entity that runs business-to-business sales for BigBasket. It was reported that  Tata may infuse additional capital into BigBasket, which may enhance its holding to about 80 per cent and may buy out Chinese e-commerce giant Alibaba's stake.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :1mgTata SonsOnline medicine salesonline pharmacyE-PharmaTata group

Next Story